Positive ANA and anti-ds-DNA antibodies, low C3 protein, lupus nephritis class III, acute cutaneous manifestations, seizures, and the evident fluid accumulation all sum up to 35 points on the 2019 EULAR/ACR criteria. This evidence concerns the gene BTG3 and lupus nephritis.